OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO. Stock

Certificat

DE000GZ0G9A3

Market Closed - BOERSE MUENCHEN 14:26:17 2024-05-21 EDT
12.36 EUR +1.15% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO.
Current month-1.90%
1 month-2.29%
Date Price Change
24-05-21 12.36 +1.15%
24-05-20 12.22 -0.33%
24-05-17 12.26 +0.74%
24-05-16 12.17 +0.41%
24-05-15 12.12 -2.42%

Real-time BOERSE MUENCHEN

Last update May 21, 2024 at 02:26 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GZ0G9A
ISINDE000GZ0G9A3
Date issued 2022-09-21
Strike 369.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 12.24
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 15.66
Lowest since issue 7.32

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
234.9 USD
Average target price
279 USD
Spread / Average Target
+18.79%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW